Evaluation of Botulinum TOXin Type A in the Treatment of Buerger's Disease
Evaluation of Botulinum TOXin Type A in the Treatment of Buerger's Disease
Not yet recruiting · NCT05698979 · Registry updated 2026-07-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of Botulinum TOXin Type A in the Treatment of Buerger's Disease | Arterial Occlusive Diseases, Embolism and Thrombosis, Raynaud disease, Skin and Connective Tissue Diseases, cardiovascular disorder, livedoid vasculopathy, peripheral vascular disease, skin disorder, skin vascular disease, thromboangiitis obliterans, thrombotic disease, vascular disorder, vasculitis | Not yet recruiting | Phase 3 | 2026-07-23 | NCT05698979 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University Hospital, Toulouse | 216 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University Hospital Toulouse | Toulouse | France | 1 |